Symbols / PRPO Stock $28.47 -4.51% Precipio, Inc.

Healthcare • Diagnostics & Research • United States • NCM
PRPO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Ilan Danieli
Exch · Country NCM · United States
Market Cap 50.81M
Enterprise Value 51.77M
Income -363.00K
Sales 24.05M
FCF (ttm) 210.12K
Book/sh 8.18
Cash/sh 1.49
Employees 61
Insider 10d —
IPO Jun 30, 2017
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 72.99
PEG —
P/S 2.11
P/B 3.48
P/C —
EV/EBITDA 224.13
EV/Sales 2.15
Quick Ratio 1.24
Current Ratio 1.61
Debt/Eq 25.09
LT Debt/Eq —
EPS (ttm) -0.23
EPS next Y 0.39
EPS Growth —
Revenue Growth 22.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-13
Earnings (prior) 2023-11-13
ROA -3.92%
ROE -2.72%
ROIC —
Gross Margin 44.52%
Oper. Margin 8.09%
Profit Margin -1.51%
Shs Outstand 1.78M
Shs Float 1.42M
Insider Own 11.94%
Instit Own 17.20%
Short Float 0.55%
Short Ratio 0.30
Short Interest 9.09K
52W High 33.63
vs 52W High -15.36%
52W Low 6.29
vs 52W Low 352.90%
Beta 1.38
Impl. Vol. —
Rel Volume 1.16
Avg Volume 28.89K
Volume 33.46K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $29.81
Price $28.46
Change -4.51%
About

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$28.47
Latest analyst target
3. DCF / Fair value
$2.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$28.47
Low
—
High
—
Mean
—
News
RSS: Latest PRPO news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 COHEN DAVID SETH Director — 445 $29.49 $13,123
2026-04-15 COSSMAN JEFFREY M.D. Director — 365 $29.49 $10,764
2026-04-15 VALAURI CHRISTINA RIZOPOULOS Director — 93 $29.49 $2,743
2026-04-01 SABET AHMED ZAKI Chief Operating Officer — 19 $27.93 $531
2026-01-15 COHEN DAVID SETH Director — 546 $24.00 $13,104
2026-01-15 COSSMAN JEFFREY M.D. Director — 437 $24.00 $10,488
2026-01-15 VALAURI CHRISTINA RIZOPOULOS Director — 406 $24.00 $9,744
2026-01-15 LAPORTE KATHLEEN D Director — 520 $24.00 $12,480
2026-01-02 SABET AHMED ZAKI Chief Operating Officer — 20 $23.40 $468
2026-01-02 SABET AHMED ZAKI Chief Operating Officer — 20 $23.40 $468
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
24.05
+29.77%
18.53
+21.95%
15.20
+61.46%
9.41
Operating Revenue
24.25
+30.52%
18.58
+20.51%
15.41
+83.12%
8.42
Cost Of Revenue
13.34
+21.60%
10.97
+19.54%
9.18
+32.99%
6.90
Reconciled Cost Of Revenue
13.34
+21.60%
10.97
+19.54%
9.18
+32.99%
6.90
Gross Profit
10.71
+41.63%
7.56
+25.61%
6.02
+139.76%
2.51
Operating Expense
11.91
+1.13%
11.78
-13.66%
13.64
-10.90%
15.31
Other Operating Expenses
11.91
+1.13%
11.78
-13.66%
13.64
-10.90%
15.31
Total Expenses
25.25
+11.00%
22.75
-0.30%
22.82
+2.74%
22.21
Total Operating Income As Reported
-1.20
+71.49%
-4.22
+44.67%
-7.62
+40.45%
-12.80
EBITDA
1.46
+154.09%
-2.70
+37.40%
-4.32
+59.44%
-10.65
Normalized EBITDA
0.67
+124.90%
-2.70
+55.23%
-6.04
+46.46%
-11.28
Reconciled Depreciation
1.75
+15.80%
1.51
-0.26%
1.52
-0.20%
1.52
EBIT
-0.29
+93.12%
-4.22
+27.75%
-5.83
+52.04%
-12.17
Total Unusual Items
0.79
0.00
-100.00%
1.72
+172.58%
0.63
Total Unusual Items Excluding Goodwill
0.79
0.00
-100.00%
1.72
+172.58%
0.63
Special Income Charges
0.79
0.00
-100.00%
1.72
+6780.00%
0.03
Other Special Charges
-0.79
—
-1.72
-6780.00%
-0.03
Net Income
-0.36
+91.54%
-4.29
+26.70%
-5.85
+52.04%
-12.20
Pretax Income
-0.36
+91.54%
-4.29
+26.70%
-5.85
+51.94%
-12.18
Net Non Operating Interest Income Expense
-0.07
+1.35%
-0.07
-311.11%
-0.02
-50.00%
-0.01
Interest Expense Non Operating
0.07
-1.35%
0.07
+311.11%
0.02
+50.00%
0.01
Net Interest Income
-0.07
+1.35%
-0.07
-311.11%
-0.02
-50.00%
-0.01
Interest Expense
0.07
-1.35%
0.07
+311.11%
0.02
+50.00%
0.01
Other Income Expense
0.91
—
1.78
+182.88%
0.63
Other Non Operating Income Expenses
0.12
—
0.07
+160.00%
0.03
Gain On Sale Of Security
—
—
—
0.61
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-0.36
+91.54%
-4.29
+26.70%
-5.85
+51.94%
-12.18
Net Income From Continuing Operation Net Minority Interest
-0.36
+91.54%
-4.29
+26.70%
-5.85
+52.04%
-12.20
Net Income From Continuing And Discontinued Operation
-0.36
+91.54%
-4.29
+26.70%
-5.85
+52.04%
-12.20
Net Income Continuous Operations
-0.36
+91.54%
-4.29
+26.70%
-5.85
+51.94%
-12.18
Minority Interests
—
—
0.00
+100.00%
-0.03
Normalized Income
-1.15
+73.15%
-4.29
+43.35%
-7.57
+40.99%
-12.83
Net Income Common Stockholders
-0.36
+91.54%
-4.29
+26.70%
-5.85
+52.04%
-12.20
Diluted EPS
-0.23
+92.15%
-2.93
+35.03%
-4.51
+57.97%
-10.73
Basic EPS
-0.23
+92.15%
-2.93
+35.03%
-4.51
+57.97%
-10.73
Basic Average Shares
1.61
+9.52%
1.47
+12.92%
1.30
+14.09%
1.14
Diluted Average Shares
1.61
+9.52%
1.47
+12.92%
1.30
+14.09%
1.14
Diluted NI Availto Com Stockholders
-0.36
+91.54%
-4.29
+26.70%
-5.85
+52.04%
-12.20
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
21.32
+25.42%
17.00
-6.10%
18.10
-15.82%
21.50
Current Assets
6.04
+74.99%
3.45
-6.27%
3.68
-35.52%
5.71
Cash Cash Equivalents And Short Term Investments
2.65
+90.86%
1.39
-7.52%
1.50
-56.40%
3.44
Cash And Cash Equivalents
2.65
+90.86%
1.39
-7.52%
1.50
-56.40%
3.44
Cash Financial
2.65
+90.86%
1.39
-7.52%
1.50
-56.40%
3.44
Receivables
1.98
+148.31%
0.80
-38.59%
1.30
+25.58%
1.04
Accounts Receivable
1.98
+148.31%
0.80
-38.59%
1.30
+25.58%
1.04
Gross Accounts Receivable
3.03
+68.84%
1.79
-53.68%
3.87
+14.25%
3.39
Allowance For Doubtful Accounts Receivable
-1.04
-5.03%
-0.99
+61.31%
-2.57
-9.26%
-2.35
Inventory
0.94
+29.14%
0.72
+88.54%
0.38
-45.76%
0.71
Other Current Assets
0.47
-12.99%
0.54
+8.89%
0.49
-4.99%
0.52
Total Non Current Assets
15.28
+12.79%
13.54
-6.06%
14.42
-8.71%
15.79
Net PPE
4.29
+163.15%
1.63
+6.95%
1.52
-19.61%
1.90
Gross PPE
6.16
+89.01%
3.26
+12.27%
2.90
-3.23%
3.00
Accumulated Depreciation
-1.87
-14.69%
-1.63
-18.16%
-1.38
-24.95%
-1.10
Machinery Furniture Equipment
1.33
+7.40%
1.24
+10.88%
1.12
+10.55%
1.01
Construction In Progress
0.03
-68.60%
0.09
+186.67%
0.03
-11.76%
0.03
Other Properties
4.80
+148.63%
1.93
+10.17%
1.75
-10.25%
1.95
Goodwill And Other Intangible Assets
10.92
-8.00%
11.87
-7.40%
12.82
-6.90%
13.77
Other Intangible Assets
10.92
-8.00%
11.87
-7.40%
12.82
-6.90%
13.77
Other Non Current Assets
0.07
+48.89%
0.04
-40.79%
0.08
-41.09%
0.13
Total Liabilities Net Minority Interest
6.76
+37.82%
4.90
+33.50%
3.67
-28.52%
5.14
Current Liabilities
3.75
-12.15%
4.27
+35.98%
3.14
-27.98%
4.36
Payables And Accrued Expenses
1.84
-25.10%
2.46
+45.51%
1.69
-46.03%
3.13
Payables
1.34
+69.41%
0.79
-12.98%
0.91
-57.38%
2.13
Accounts Payable
1.13
+83.01%
0.62
-0.64%
0.62
-69.54%
2.04
Current Accrued Expenses
0.50
-69.84%
1.67
+113.41%
0.78
-21.86%
1.00
Pensionand Other Post Retirement Benefit Plans Current
0.98
+2.30%
0.95
+26.66%
0.75
+53.56%
0.49
Total Tax Payable
0.21
+20.81%
0.17
-39.72%
0.29
+215.38%
0.09
Current Debt And Capital Lease Obligation
0.65
+4.34%
0.62
+6.32%
0.58
-5.03%
0.62
Current Debt
0.03
-89.90%
0.30
+26.38%
0.23
-7.84%
0.26
Other Current Borrowings
0.03
-89.90%
0.30
+26.38%
0.23
-7.84%
0.26
Current Capital Lease Obligation
0.62
+90.46%
0.33
-7.14%
0.35
-3.05%
0.36
Current Deferred Liabilities
0.28
+21.55%
0.23
+110.91%
0.11
-7.56%
0.12
Current Deferred Revenue
0.28
+21.55%
0.23
+110.91%
0.11
-7.56%
0.12
Total Non Current Liabilities Net Minority Interest
3.00
+376.07%
0.63
+18.83%
0.53
-31.57%
0.78
Long Term Debt And Capital Lease Obligation
3.00
+376.07%
0.63
+18.83%
0.53
-31.57%
0.78
Long Term Debt
0.05
-38.96%
0.08
-27.36%
0.11
-20.90%
0.13
Long Term Capital Lease Obligation
2.96
+433.75%
0.55
+30.35%
0.42
-33.80%
0.64
Stockholders Equity
14.56
+20.40%
12.09
-16.18%
14.43
-11.49%
16.30
Common Stock Equity
14.56
+20.40%
12.09
-16.18%
14.43
-11.49%
16.30
Capital Stock
0.02
+20.00%
0.01
+7.14%
0.01
+27.27%
0.01
Common Stock
0.02
+20.00%
0.01
+7.14%
0.01
+27.27%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1.78
+19.23%
1.49
+5.18%
1.42
+24.46%
1.14
Ordinary Shares Number
1.78
+19.23%
1.49
+5.18%
1.42
+24.46%
1.14
Additional Paid In Capital
117.35
+2.47%
114.52
+1.74%
112.56
+3.66%
108.59
Retained Earnings
-102.80
-0.35%
-102.44
-4.37%
-98.15
-6.34%
-92.30
Minority Interest
—
0.00
0.00
-100.00%
0.07
Total Equity Gross Minority Interest
14.56
+20.40%
12.09
-16.18%
14.43
-11.84%
16.37
Total Capitalization
14.61
+20.02%
12.17
-16.26%
14.54
-11.57%
16.44
Working Capital
2.29
+378.90%
-0.82
-251.57%
0.54
-59.90%
1.35
Invested Capital
14.64
+17.40%
12.47
-15.59%
14.77
-11.51%
16.69
Total Debt
3.65
+191.54%
1.25
+12.28%
1.12
-19.83%
1.39
Capital Lease Obligations
3.58
+306.83%
0.88
+13.42%
0.78
-22.73%
1.00
Net Tangible Assets
3.64
+1518.67%
0.23
-86.03%
1.61
-36.42%
2.53
Tangible Book Value
3.64
+1518.67%
0.23
-86.03%
1.61
-36.42%
2.53
Derivative Product Liabilities
—
—
—
0.00
Interest Payable
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Preferred Shares Number
2.59
+0.00%
2.59
+0.00%
2.59
+0.00%
2.59
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Cash Flow From Continuing Operating Activities
0.69
+56.04%
0.44
+112.33%
-3.56
+53.90%
-7.72
Net Income From Continuing Operations
-0.36
+91.54%
-4.29
+26.70%
-5.85
+51.94%
-12.18
Depreciation Amortization Depletion
1.75
+15.80%
1.51
-0.26%
1.52
-0.20%
1.52
Depreciation
1.75
+15.80%
1.51
-0.26%
1.52
-0.20%
1.52
Depreciation And Amortization
1.75
+15.80%
1.51
-0.26%
1.52
-0.20%
1.52
Other Non Cash Items
-0.18
-3740.00%
0.01
+100.29%
-1.72
-8076.19%
-0.02
Stock Based Compensation
1.45
-22.75%
1.88
+8.18%
1.74
-54.35%
3.80
Provisionand Write Offof Assets
0.18
+176.56%
0.06
-70.64%
0.22
-46.31%
0.41
Operating Gains Losses
0.02
—
-0.07
+89.27%
-0.61
Gain Loss On Investment Securities
—
—
—
-0.61
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-2.17
-270.79%
1.27
+109.57%
0.61
+194.25%
-0.64
Change In Receivables
-1.36
-410.96%
0.44
+190.68%
-0.48
+35.17%
-0.74
Changes In Account Receivables
-1.36
-410.96%
0.44
+190.68%
-0.48
+35.17%
-0.74
Change In Inventory
-0.21
+37.94%
-0.34
-204.94%
0.32
+325.00%
-0.14
Change In Payables And Accrued Expense
-0.45
-146.94%
0.96
+82.42%
0.53
+422.56%
-0.16
Change In Accrued Expense
-0.97
-199.08%
0.97
+39.68%
0.70
+312.16%
-0.33
Change In Payable
0.51
+5230.00%
-0.01
+94.08%
-0.17
-202.42%
0.17
Change In Account Payable
0.51
+5230.00%
-0.01
+94.08%
-0.17
-202.42%
0.17
Change In Other Working Capital
0.05
-59.02%
0.12
+1455.56%
-0.01
-108.91%
0.10
Change In Other Current Assets
0.05
-84.16%
0.30
-32.82%
0.45
-8.15%
0.49
Change In Other Current Liabilities
-0.24
-10.55%
-0.22
-5.83%
-0.21
-13.19%
-0.18
Investing Cash Flow
-0.33
-46.19%
-0.22
-76.98%
-0.13
+54.51%
-0.28
Cash Flow From Continuing Investing Activities
-0.33
-46.19%
-0.22
-76.98%
-0.13
+54.51%
-0.28
Net PPE Purchase And Sale
-0.33
-46.19%
-0.22
-76.98%
-0.13
+54.51%
-0.28
Purchase Of PPE
-0.33
-46.19%
-0.22
-76.98%
-0.13
+54.51%
-0.28
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.33
-46.19%
-0.22
-76.98%
-0.13
+54.51%
-0.28
Gain Loss On Sale Of Business
—
0.00
+100.00%
-0.07
0.00
Financing Cash Flow
0.90
+374.47%
-0.33
-118.89%
1.74
+874.22%
-0.23
Cash Flow From Continuing Financing Activities
0.90
+374.47%
-0.33
-118.89%
1.74
+874.22%
-0.23
Net Issuance Payments Of Debt
-0.48
-17.20%
-0.41
+19.09%
-0.50
-37.81%
-0.36
Issuance Of Debt
0.00
-100.00%
0.25
0.00
—
Repayment Of Debt
-0.48
+27.40%
-0.66
-30.62%
-0.50
-37.81%
-0.36
Long Term Debt Issuance
0.00
-100.00%
0.25
0.00
—
Long Term Debt Payments
-0.48
+27.40%
-0.66
-30.62%
-0.50
-37.81%
-0.36
Net Long Term Debt Issuance
-0.48
-17.20%
-0.41
+19.09%
-0.50
-37.81%
-0.36
Net Common Stock Issuance
0.00
-100.00%
0.08
-96.53%
2.25
+1640.31%
0.13
Proceeds From Stock Option Exercised
1.38
0.00
0.00
-100.00%
0.01
Net Other Financing Charges
—
—
—
—
Changes In Cash
1.26
+1216.81%
-0.11
+94.18%
-1.94
+76.37%
-8.22
Beginning Cash Position
1.39
-7.52%
1.50
-56.40%
3.44
-70.47%
11.67
End Cash Position
2.65
+90.86%
1.39
-7.52%
1.50
-56.40%
3.44
Free Cash Flow
0.36
+66.20%
0.22
+105.86%
-3.69
+53.93%
-8.00
Interest Paid Supplemental Data
0.10
+17.65%
0.09
+102.38%
0.04
-6.67%
0.04
Common Stock Issuance
0.00
-100.00%
0.08
-96.53%
2.25
+1640.31%
0.13
Issuance Of Capital Stock
0.00
-100.00%
0.08
-96.53%
2.25
+1640.31%
0.13
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category